Impacts of Irritable Bowel Syndrome associated with anxiety and depression on the quality of life of the population
DOI:
https://doi.org/10.33448/rsd-v12i1.39306Keywords:
Intestinal Bowel Syndrome; Anxiety; Depression; Healthy diet.Abstract
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder (GIF) that affects the individual chronically. In addition, it is a pathology associated, in the vast majority of cases, with psychological factors, such as anxiety and depression. The objective of this study is to verify the impacts of IBS combined with mental disorders on the quality of life of the general population and also to identify the benefits of different types of treatments in the symptomatology of the disease. Considering this, this article is a systematic review of the literature, with the purpose of answering the following question: “What are the impacts that irritable bowel syndrome associated with anxiety and depression can bring to the quality of life of the general population?”. Among the criteria was the date of publication, between 2012 and 2022, found in databases such as the Virtual Health Library (BVS), Scientif Electronic Library Online (SciELO), National Library of Medicine (PubMed), EbscoHost. Thirty articles were identified, of which 23 fit the pre-established criteria. It can be seen that, undeniably, psychological disorders such as anxiety and depression are shown to cause this clinic, therefore psychological and pharmacological accompaniments as a treatment, associated with a healthy diet, are very effective in improving the quality of life of these patients.
References
Barbuti, R. C. et al. (2020). Gut microbiota, prebiotics, probiotics, and synbiotics in gastrointestinal and liver diseases: proceedings of a joint meeting of the brazilian society of hepatology (SBH), brazilian núcleos for the study of helicobacter pylori and microbiota (NBEHPM), and brazilian federation of gastroenterology (FBG). Arquivos de Gastroenterologia, 57, 381-398.
Bonfiglio, F. et al. (2018). Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. Gastroenterology, 155, (1), 168–179.
Burns, G. L.; Talley, N. J.; Keely, S. (2022). Immune responses in the irritable bowel syndromes: time to consider the small intestine. BMC Medicine, 20, (1).
Cabrita, B. G. A. (2021) Papel dos antidepressivos na síndrome do intestino irritável. repositorio.ul.pt.
Cavalcante, J. P. R. et al. (2020). Ocorrência de Ansiedade e Depressão em Pacientes com Síndrome do Intestino Irritável: Revisão Sistemática com Meta-análise. Brazilian Journal of Health Review, 410–420.
Duque, G. M. et al. (2021). A influência psicossomática em portadores da síndrome do intestino irritável. Revista Científica da Faculdade de Medicina de Campos, 16, (2), 56–65.
Emre, E.; Tazegul, G.; Akin, M. (2022). Rome IV Criteria-Defined Irritable Bowel Syndrome in Atopic Patients and the Effect of Anxiety and Depression: A Case–Control Study. Turkish Journal of Gastroenterology, 33, (5).
Guerreiro, M. M. D. (2018). Efeito da exclusão de FODMAPs na sintomatologia e qualidade de vida de indivíduos com síndrome do intestino irritável. repositorio.ul.pt.
Kutschke, J.; Harris, J. R.; Bengtson, M.-B. (2022). The relationships between IBS and perceptions of physical and mental health—a Norwegian twin study. BMC Gastroenterology, 22, (1).
Leite Da Silva, M. et al. (2020). Papel da microbiota no tratamento da Síndrome do Intestino Irritável Orientado por: Setembro 2020 [s.l: s.n.].
Lin, H. et al. (2021). The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors. Microbial Cell Factories, 20, (1).
Loosen, S. H. et al. (2022). Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany. BMC gastroenterology, 22, (1), 48.
Lopes, S. S. et al. (2019). Evaluation of carbohydrate and fiber consumption in patients with irritable bowel syndrome in outpatient treatment. Arquivos de Gastroenterologia, 56, 03–09.
Luo, M. et al. (2022) Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation. Journal of Health, Population and Nutrition, 41, (1).
Magdy, R. et al. (2022). The potential impact of nutritional intake on symptoms severity in patients with comorbid migraine and irritable bowel syndrome. BMC Neurology, 22, (1).
Mendonça, A. P. M. de et al. (2020). Nutritional status, quality of life and life habits of women with irritable bowel syndrome: a case-control study. Arquivos de Gastroenterologia,
, (2), 114–120.
Mirely, K. et al. (2017) Ansiedade em universitários na área da saúde. Digital, P. E. Ansiedade em universitários na área da saúde.
Moser, G.; Fournier, C.; Peter, J. (2018). Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wiener medizinische Wochenschrift (1946),168, (3-4), 62–66.
Mohammad, B. Y.; Al-Dohouky, L; Mohammed, A. (2019). A Prevalence of anti-tissue transglutaminase antibodies in patients with irritable bowel syndrome in Duhok city. Journal of Coloproctology, 39, (4), 346–350.
Nedelcut, S.; Leucuta, D.-C.; Dumitrscu, D. L. (2018). Overlapping of functional esophageal disorders and irritable bowel syndrome, in musicians and athletes. Revista Brasileira de Medicina do Esporte, 24, 69–72.
Passos, M. Do C. F. et al. (2020). Systematic review with meta-analysis: lubiprostone efficacy on the treatment of patients with constipation. Arquivos De Gastroenterologia, 57, (4), 498–506.
Soares, R. L. S. (2018). Irritable bowel syndrome, food intolerance and non-celiac gluten sinsitivity. A new clinical challenge. Arquivos de Gastroenterologia, 55, (4), 417–422.
Wu, S. et al. (2022). Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study. BMC Medicine, 20, (1).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Fernanda Borges de Carvalho; Natália de Fátima Gonçalves Amâncio; Kelen Cristina Estavanate de Castro
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
